Natural Capsules Limited — Updates, 30-05-2025: Press Release

Natural Capsules has announced a board meeting to review the financial results for the quarter and half-year. Q4FY25 revenues were ₹44.97 Cr with EBITDA margins at 9.74%, and full-year revenues reached ₹169.21 Cr with 10.35% EBITDA margins. An 88% US duty on Chinese HPMC capsules versus 14% on Indian ones is boosting the company’s HPMC export demand. Softening gelatin raw material prices should aid margins. The API segment faces China capacity challenges but rising utilization hints at profitability from Q1 FY26.